Driving the Connected Healthcare Market to a Wider Standardization

eDeviceWith more than 200,000 connected medical devices currently in the field and a strong position as pioneer and worldwide leader of the connected healthcare market, eDevice was the key representative of the Telehealth industry participating in this first oneM2M Interoperability Test. The result of the tests demonstrated interoperability between eDevice's HealthGO Mini medical hub for Remote Patient Monitoring (RPM) and oneM2M servers from various companies, including Cisco Systems (CSCO), Huawei Technologies, LG, Qualcomm (QCOM), HP & Fraunhofer, amongst others. These successful tests represent an important step for the eHealth industry, which requires standards for widespread expansion of connected care technologies. oneM2M fosters standardized end-to-end Remote Patient Monitoring solutions by connecting together the medical standards of the industry, including Continua, BLE, HL7, and more.

With HealthGO Mini, Healthcare organizations can now benefit from a scalable, robust and interoperable solution for retrieving vital signs from patients at home enabling advanced telehealth programs. HealthGO Mini is a standalone product installed at patients’ home that communicates seamlessly with off-the-shelf medical sensors and transfers measurements over eDevice’s 3G network through a oneM2M compliant infrastructure delivering health data to existing medical databases.

With these promising results, eDevice paves the way to mass production of interoperable telehealth solutions. As an ISO-13485 certified and FDA listed company, the company confirms its commitment to standards, even pushing for a wider standardization in the connected Healthcare industry.

About eDevice
At the crossroads of telecom and medical fields, eDevice pioneered the Telehealth connectivity space. Since 2002, several market leaders have relied on eDevice to provide solutions that securely and safely transmit medical data between their patients and their systems, with continuous growth and more than 200.000 patients connected with eDevice technology. eDevice develops solutions for M2M and eHealth connectivity, including Telehealth hubs, network converters, cellular modems, and 3G modules. Through partnership with technology leaders, the company brings innovative connectivity solutions to medical device manufacturers.

About oneM2M
oneM2M is the global standards initiative that covers requirements, architecture, API specifications, security solutions and interoperability for M2M and IoT technologies. oneM2M was formed in 2012 and consists of eight of the world's preeminent standards development organizations (incl. ATIS, TIA, ETSI), together with six industry fora or consortia (incl. Broadband Forum, Continua Alliance) and over 200 member organizations. oneM2M specifications provide a framework to support applications and services such as the smart grid, connected car, home automation, public safety, and health. oneM2M actively encourages industry associations with specific application requirements to participate in oneM2M, in order to ensure that the solutions developed support their specific needs.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...